Activation of endogenous T cell reactions through checkpoint blockade and/or DC vaccines appears to be safe, but has yet to demonstrate its clinical potency when used like a monotherapy for the treatment of AML
Activation of endogenous T cell reactions through checkpoint blockade and/or DC vaccines appears to be safe, but has yet to demonstrate its clinical potency when used like a monotherapy for the treatment of AML. immunotherapeutic ideas in conjunction with hematopoietic stem cell transplantation. Besides, we have included important medical trials that are currently running or […]
Recent Comments